• Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
    • Managing Risky Products
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About
  • Donate
Search
  • Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
    • Managing Risky Products
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About
  • Donate
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
FDAReview.org
  • Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
    • Managing Risky Products
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About
  • Donate

Raymond March

104 POSTS 0 COMMENTS
Raymond J. March is a Research Fellow at the Independent Institute and Assistant Professor of Economics at North Dakota State University.
All Blog Posts | Full bio and publications

President Biden Faces Longstanding Challenge to Lower Insulin Prices. Will He...

Raymond March - February 10, 2021 0

Capping Insulin Copays Won’t Cure Insulin Price Woes

Raymond March - January 6, 2021 0

New COVID-19 Vaccines, Same Sluggish FDA

Raymond March - December 15, 2020 0

Public Health Bureaucracies Consolidate Power as Pandemic Continues

Raymond March - October 7, 2020 0

Economic Miscalculation and the Covid-19 Pandemic

Raymond March - October 1, 2020 0

FDA Approves Blood Plasma as Covid-19 Treatment

Raymond March - September 10, 2020 0

Promising Alzheimer’s Drug on FDA Fast Track

Raymond March - August 26, 2020 0

Is the Covid-19 Pandemic Spreading Affinity for Socialism? It Shouldn’t!

Raymond March - August 18, 2020 0

Trump Signs More Executive Orders as a Last-Ditch Effort to Lower...

Raymond March - August 4, 2020 0

State Mismanagement of Covid-19 Data Continues

Raymond March - July 30, 2020 0
1234...11Page 3 of 11
  • Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
    • Managing Risky Products
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About
  • Donate
© 2023 Independent Institute, 100 Swan Way, Oakland CA 94621-1428 | (510) 632‑1366.